Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
139.50    0.00 (0.00%)
Bid:
137.00
Ask:
142.00
Spread: 5.00 (3.65%)
Market Cap: £78.87m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

Share Dealings

23 Dec 2025 14:00

RNS Number : 7043M
Marwyn Value Investors Limited
23 December 2025
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

23 December 2025

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

SHARE DEALINGS

Further to the Company's announcement on 20 October 2025, Marwyn employees have bought 37,761 Ordinary Shares in the Company from Marwyn Capital Management Limited ("MCML") at 135.69p per share, being the same total cost per share that MCML acquired such shares for on 16 October 2025. Following this, the aggregate holding of Ordinary Shares by James Corsellis, Chief Investment Officer of Marwyn Investment Management LLP, the manager of the Company, and MCML (being an entity wholly owned by James Corsellis) is 6,933,872 Ordinary Shares, representing approximately 12.26% of the Company's voting rights.

Whilst neither James Corsellis or MCML are Persons Discharging Managerial Responsibility ("PDMR") within the meaning of the UK version of Regulation (EU) 596/2014, as incorporated in the UK by virtue of the European Union (Withdrawal) Act 2018, as amended in relation to the Company, they have voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if they were PDMRs in relation to the Company.

 

Company enquiries:

Marwyn Value Investors Limited

Scott Danks

scottdanks@marwyn.com

 

Company Secretary - Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com

1 Grenville Street

St Helier

Jersey JE2 4UF

 

Investor Relations - KK Advisory Limited

Kam Bansil

020 7039 1901

 

PR Adviser - FGS GlobalRollo Head 07768 994987Chris Sibbald 07855 955531

 

Corporate Broker - Panmure Liberum Limited

Chris Clarke

0203 100 2200

 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFVFTLVFIE
Date   Source Headline
2nd Jun 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Jun 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Jun 202610:00 amRNSNet Asset Value - Ordinary Shares
27th May 20265:03 pmRNSNotification of Major Interests in Shares
26th May 20264:43 pmRNSShare Acquisition
26th May 202611:00 amRNSNet Asset Values
18th May 202611:00 amRNSNet Asset Values
11th May 202611:00 amRNSNet Asset Values
5th May 202610:21 amRNSNet Asset Value - 2021 Realisation Shares
5th May 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
5th May 202610:00 amRNSNet Asset Value - Ordinary Shares
30th Apr 20267:00 amRNSAnnual Financial Report
29th Apr 20267:00 amRNSInterim Dividend to Ordinary Shareholders
20th Apr 202611:00 amRNSNet Asset Values
16th Apr 202611:00 amRNSNet Asset Values
15th Apr 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Apr 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Apr 202610:00 amRNSNet Asset Value - Ordinary Shares
30th Mar 202611:00 amRNSNet Asset Values
26th Mar 20261:30 pmRNSShare Transfer
23rd Mar 202611:00 amRNSNet Asset Values
19th Mar 20262:00 pmRNSNotification of Major Interests in Shares
16th Mar 202611:00 amRNSNet Asset Values
9th Mar 202611:00 amRNSNet Asset Values
3rd Mar 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
3rd Mar 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
3rd Mar 202610:00 amRNSNet Asset Value - Ordinary Shares
23rd Feb 202611:00 amRNSNet Asset Values
16th Feb 202611:00 amRNSNet Asset Values
9th Feb 202611:00 amRNSNet Asset Values
3rd Feb 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
3rd Feb 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
3rd Feb 202610:00 amRNSNet Asset Value - Ordinary Shares
29th Jan 20267:00 amRNSInterim Dividend to Ordinary Shareholders
28th Jan 20266:29 pmRNSNotification of Major Interests in Shares
26th Jan 202611:00 amRNSNet Asset Values
19th Jan 202611:00 amRNSNet Asset Values
16th Jan 202611:00 amRNSNet Asset Values
15th Jan 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 202610:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 202610:00 amRNSNet Asset Value - Ordinary Shares
8th Jan 202611:28 amRNSShare Transfer
6th Jan 202612:49 pmRNSNotification of Major Interests in Shares
23rd Dec 20252:00 pmRNSShare Dealings
23rd Dec 20252:00 pmRNSShare Dealings
22nd Dec 202511:00 amRNSNet Asset Values
18th Dec 20254:00 pmRNSShare Dealings
18th Dec 20254:00 pmRNSShare Dealings
15th Dec 202511:00 amRNSNet Asset Values
10th Dec 202512:14 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.